Driving Innovation Through Collaboration

Primary objective

International, multicenter, open label, randomized (2:1), controlled trial comparing remote symptoms monitoring using Resilience PRO (“RPM”) Intervention arm with Usual Care (Control arm) in cancer patients treated with systemic therapy.

The primary objective of RC-102 is to assess the impact of Remote Patient Monitoring (Resilience PRO) on health-related quality of life (HR‑QoL) between baseline (M0) and 3 months (M3). The primary endpoint is the proportion of patients with an improvement in HR‑QoL on the EORTC QLQ‑C30 at 3 months versus baseline.

Primary objective

Randomized Controlled Trial Comparing Remote Patient Monitoring vs Standard Care in IBD Patients Initiating or Changing Advanced Therapy (GC-102).

The primary objective is to compare the healthcare resource utilisation of continuous monitoring at home using a digital remote patient monitoring solution compared to standard monitoring in patients with CD or UC initiating an advanced therapy OR undergoing a substantial change in the treatment of the disease. (superiority).

Primary objective

Efficacy of Remote Monitoring in Patients Treated for Moderate to Major Depressive Episodes (EC-102)
‍
‍The primary objective is the 6‑month response rate, defined as a ≥50% reduction in the MADRS score at 6 months. Secondary objectives include remission, relapse, quality of life, and the health‑economic impact of the tool.